Overview

Study of Local Administration of DepoTXA for Reduced Postsurgical Bleeding in Subjects Undergoing TKA

Status:
Terminated
Trial end date:
2017-11-27
Target enrollment:
Participant gender:
Summary
This is a Phase 2, randomized, single-blind, active-controlled dose-ranging study in subjects scheduled to undergo total knee arthroplasty (TKA).
Phase:
Phase 2
Details
Lead Sponsor:
Pacira Pharmaceuticals, Inc
Treatments:
Tranexamic Acid